DCVC Bio

DCVC Bio

San Francisco, Californiadcvc.com

Overview

DCVC Bio is a venture capital firm that invests in early-stage deep tech startups in the life sciences. It is the life sciences-focused investment arm of the parent firm, DCVC (Data Collective). The firm's strategy is to invest in scientific breakthroughs and computation-enhanced platforms that can generate new arrays of treatments or products, rather than investing in specific drugs or molecules. Its focus areas include therapeutics platforms, companies improving agriculture and food systems, and industrial biotechnologies that unify data and leverage artificial intelligence and automation. DCVC Bio was co-founded in 2018 by DCVC founders Matt Ocko and Zachary Bogue, along with Dr. John Hamer and Dr. Kiersten Stead.

Portfolio Companies

34

Website

dcvc.com

Investments

CompanyDateStageLead
LatusMay 2026Series A ExtensionLead
SidewinderApr 2026Series BCo-investor
Sidewinder TherapeuticsApr 2026Series BCo-investor
AgZenMar 2026Series BLead
GenZ TechnologyMar 2026Series BLead

Key People

Zachary Bogue

Co-Founder and Co-Managing Partner

John Hamer

Managing Partner, DCVC Bio

Kiersten Stead

Managing Partner, DCVC Bio

Matt Ocko

Co-Managing Partner

Sector & Stage Mix

Industry, funding stage, and valuation band breakdowns.

Premium
SeedSeries ASeries BGrowth

Unlock portfolio analytics

Sign up to view full sector, stage, and valuation breakdowns for this investor.

Investment Activity

Yearly cadence, pace, and funding raised over time.

Premium
2021
2022
2023
2024
2025
2026

Unlock portfolio analytics

Sign up to explore yearly investment trends and funding raised over time.

FAQ

Firmographic Details

HeadquartersSan Francisco, California
Year FoundedN/A

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.